Navigation Links
The Effects Of Fish On Pregnant Women Questioned

A new study shows pregnant women with asthma can reduce their risk of having asthmatic children by eating oily fish. Results show asthmatic // mothers who ate oily fish, such as salmon and trout, during pregnancy were about 70-percent less likely to have children with asthma. In fact, researchers say the more oily fish a woman consumed, the less likely her child was to develop asthma. Children with non-asthmatic mothers did not benefit from having their mothers eat oily fish during pregnancy.

However, mothers who ate fish sticks during pregnancy were twice as likely to have children with asthma, regardless of whether they had asthma themselves. Researchers say the reason is fish sticks are deep-fried, and they contain omega-6 fatty acids, which encourage inflammation of the airways. Oily fish contain omega-3 fatty acids, which appear to be anti-inflammatory and lead to the reduced potential for developing asthma and allergies.
'"/>




Page: 1

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Chemotherapy Pill Has Fewer Side Effects Than IV
3. Therapy Boosts Chemotherapy Effects
4. Smoking and its Effects
5. Reducing The After Effects of Tonsillectomy
6. The Side Effects Of Estrogen Therapy
7. The Harmful Effects Of Cigarette Smoke
8. Lung Therapy Found To Have Long-Term Side Effects
9. The Effects Of Estrogen Therapy
10. The After Effects Of Pneumonia
11. The Effects Of Dental X-Rays During Pregnancy Questioned
Post Your Comments:
(Date:7/9/2008)...etic outcome after lumpectomy linked to depression...9 (HealthDay News) -- A third of women who opt for...e an asymmetry between their breasts that greatly ..., Women whose affected breast looked noticeably ...ar their cancer returning and to have symptoms of ...
(Date:7/9/2008)...ship Integrates In-Store and Online Marketing to C...erience, PITTSBURGH and NEW YORK, July 9 /PRNewsw..."GNC"), the largest global specialty retailer of,n...he leading source of,health information, today ann...ase consumer awareness and understanding of the im...
(Date:7/9/2008)...LAS and PLANO, Texas, July 9 /PRNewswire/ -- SKINT... is pleased to announce the arrival,of newly FDA-a...gen filler,in the Skintastic arsenal of little-or-...s immediate, predictable visible results, with lit...orted with EVOLENCE(R) in a,comparison study again...
(Date:7/9/2008)... DRE, Inc., a premier international...its customers that as much as $250,000 in medical ...me tax filings. , Louisvi...lus Act of 2008, in accordance with Tax Code Secti... equipment bought in 2008. This could make 2008 an...
Breaking Medicine News(10 mins):Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 2Health News:GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle 3Health News:New Injectable Collagen Filler Offers Natural Results 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...l study found that the use of Herceptin in advance... of cardiac toxicity − nearly 28 percent of ...ical trial has yet reported;The silver lining is t...be remedied with treatment. The study, published...
...open-heart surgery was performed on a 17 yr old bo...spital// (TMCH). An eight-member team led by card...ery on the boy who was suffering from an arterial ...n the 4th of August. Dr S Balakrishnan the dean ...
...undergo surgery following an early pregnancy failu...under general anesthesia//. However a new study ha... approach. Early pregnancy failure - or EPF - occ...ognized pregnancies. Cases treated with surgery ty...
...ularity of unpasteurized milk has raised questions...ple consume unpasteurized milk for a variety of re...asteurized milk are healthier and tastier, it can’...me it do fall sick. There been have instances whe...
Other Medicine News:Health News:Herceptin Use May Enhance Cardiac Toxicity, Study 2Health News:Herceptin Use May Enhance Cardiac Toxicity, Study 3Health News:Women Prefer Office Procedure during treatment of Early Pregnancy 2Health News:Women Prefer Office Procedure during treatment of Early Pregnancy 3
(Date:7/8/2008)...- McGraw-Hill Professional, a leading,global provi...d medical,communities, today announced the additio...its comprehensive online pharmacy education,resour... ). Through an alliance with,Doctor Evidence, deve...ical,studies, AccessPharmacy now provides in-conte...
(Date:7/7/2008)... Includes ANA598 and ANA773 Acting via In... Conference Call Today at 2:00 PM... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ann...ation of the Toll-Like Receptor-7 (TLR7) mechanism...n preclinical pharmacology testing,and the results...
(Date:7/7/2008)...-- OrbusNeich today announced that data,presented ...e Society of,Interventional Cardiology demonstrate... outcomes when compared to drug-eluting stents., ...principal,investigator and a professor with the Fe...ology, Department of Clinical Medicine and Cardiov...
(Date:7/6/2008)...ing Authorization Application currently ...uly 7 /- Cell Therapeutics,...the publication of results from its,randomized pha...glumex,CT-2103) with gemcitabine or vinorelbine f...tients with previously untreated non-small cell,lu...
Breaking Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5APIC launches first national C difficile prevalence study 14826 1APIC launches first national C difficile prevalence study 14826 2Cato Study Finds Iran a Surprising Model for Kidney Markets 14823 1Cato Study Finds Iran a Surprising Model for Kidney Markets 14823 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 1573 1NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 1573 2Subterfuge counter surveillance and assassination 3A The bodys fight with cervical cancer 2560 1Subterfuge counter surveillance and assassination 3A The bodys fight with cervical cancer 2560 2
...007 - Medtronic, Inc.,(NYSE:MDT) today announced ...l Trial indicates that the trial has met its prima...nical Trial is a randomized, single-blind,trial ev...M) Drug,Eluting Coronary Stent as compared to the ...m Boston Scientific Corporation,(NYSE:BSX). ENDEAV...
...rget from Lexicon,s Genetic,Research -, THE WOODLA...-,Lexicon Pharmaceuticals, Inc. today reported res...antibodies directed to a,potential new target, ang...triglycerides and cholesterol. Research suggests t...may have therapeutic,application in the treatment ...
Other Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: